Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-01-05 @ 9:43 AM
Study NCT ID:
NCT00965432
Status:
COMPLETED
Last Update Posted:
2010-02-08
First Post:
2009-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107
Sponsor:
Seaside Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
22006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Randall Carpenter, President and CEO
Old Organization:
Seaside Therapeutics, LLC
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |